When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
PTI - Proteostasis down 48% premarket on disappointing data on CF candidates
Yumanity Therapeutics Inc Com
Proteostasis Therapeutics (NASDAQ:PTI) slumps 48% premarket on increased volume on the heels of its announcement of Phase 1 data on cystic fibrosis (CF) triplet therapy of PTI-801 (CFTR corrector), PTI-808 (CFTR potentiator) and PTI-428 (CFTR amplifier) and separate studies of PTI-801 and PTI-428 as add-on therapies to background tezacaftor/ivacaftor [Vertex Pharmaceuticals' (NASDAQ:VRTX) Symdeko].
More news on: Proteostasis Therapeutics, Inc., Vertex Pharmaceuticals Incorporated, Healthcare stocks news, Stocks on the move,